Your session is about to expire
← Back to Search
Radiation Therapy
Cardiac radioablation (CRA) for Ventricular Tachycardia (RAD 1901 Trial)
N/A
Waitlist Available
Led By John Stahl, MD
Research Sponsored by John Stahl
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
RAD 1901 Trial Summary
This trial will test whether a new non-invasive treatment for ventricular tachycardia is safe and effective.
Eligible Conditions
- Ventricular Tachycardia
RAD 1901 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction in ICD treatments for VT (≥ 50 percent)
Secondary outcome measures
Elimination of ICD shocks
Reduction in ICD treatments for VT (≥ 95 percent)
Severe adverse event rate ≤ 20 percent
RAD 1901 Trial Design
1Treatment groups
Experimental Treatment
Group I: Cardiac radioablation (CRA)Experimental Treatment1 Intervention
CRA delivered via linear accelerator (stereotactic body radiotherapy) to the suspected arrhythmogenic substrate to a dose of 25 Gy in 1 fraction.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineOTHER
1,931 Previous Clinical Trials
2,299,709 Total Patients Enrolled
John StahlLead Sponsor
John Stahl, MDPrincipal InvestigatorUniversity of Alabama at Birmingham (UAB)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger